P-D-R Pharma Documentation Ring

The P-D-R is an association whose members represent the scientific information departments of the leading international R&D-based pharmaceutical corporations.

Latest News from the P-D-R Company Websites

Published 19 April 2018 | 6:50 pm

Pfizer Invites Public to Listen to Webcast of April 26 Annual Meeting of Shareholders

Pfizer Inc. invites investors and the general public to listen to a webcast of the Annual Meeting of Shareholders at 9:00 a.m. (Eastern Daylight Time) on Thursday, April 26, more ...

Published 19 April 2018 | 2:28 pm

Takeda Statement Regarding Shire plc

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A more ...

Published 19 April 2018 | 2:01 pm

Employee ideas save BASF around euro58 million globally

Ludwigshafen, Germany - April 19, 2018 - Even the smallest of changes can have a big impact. BASF's initiative "Idea Management" proves this time and again, with employees more ...

Published 19 April 2018 | 12:00 pm

Personnel changes at BASF

Ludwigshafen, Germany - The Board of Executive Directors of BASF has announced the following personnel changes: more ...

Published 19 April 2018 | 7:50 am

Novartis Financial Results - Q1 2018

Today, Novartis CEO Vas Narasimhan announced the company's financial results for the first quarter of 2018. more ...

Published 19 April 2018 | 7:25 am

Novartis appoints John Tsai Head of Global Drug Development and Chief Medical Officer

Basel, April 19, 2018 - Novartis announced today the appointment of John Tsai, M.D. as Head of Global Drug Development (GDD) and Chief Medical Officer. Dr. Tsai will join more ...

Published 19 April 2018 | 7:25 am

Novartis delivered a strong first quarter and acted to become a more focused medicines company

Entresto grew to USD 200 million, +126% (cc) driven by increased uptake world wide more ...

Published 19 April 2018 | 2:30 am

Red Cross and Novo Nordisk announce ground-breaking partnership to tackle chronic care in humanitarian crises

Many more people are today affected by chronic non-communicable diseases (NCDs) than by communicable diseases. This is not reflected in resources for health in general more ...

Published 18 April 2018 | 11:35 pm

Landmark IMPACT study published in NEJM shows significant benefits of Trelegy Ellipta for patients with COPD

Once-daily single inhaler triple therapy superior to Relvar/Breo Ellipta and Anoro Ellipta across multiple endpoints including exacerbations, lung function and quality of life. more ...

Published 18 April 2018 | 10:52 pm

Sandoz signs agreement with Pear Therapeutics to develop and commercialize prescription digital therapeutics for patients with substance use disorder and opioid use disorders

Deal includes reSET®, cleared by FDA for treatment of patients with Substance Use Disorder, and reSET-O(TM), potential treatment pending FDA clearance for patients with more ...

Pharma Documentation Ring:
24 companies - 4 common aims:

  • Promote exchange of experience/networking among members
  • Encourage commercial development of new information services and systems
  • Jointly assess new and existing products and services
  • Provide a forum for the information industry
  • How to become a P-D-R member?
Next Annual General Meeting, Berlin, September 26 – 29, 2017

Next Annual General Meeting, Berlin, September 26 – 29, 2017